"Designing Growth Strategies is in our DNA"

Female Sexual Dysfunction Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug (Flibanserin, Bremelanotide, Ospemifene, Estrogen Therapy, and Others), By Disease (Hypoactive Sexual Desire Disorder (HSDD), Dyspareunia, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

Region : Global | Format: PDF | Report ID: FBI100850

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Request for Customization

Refresh Button
Booklet
  • Feb, 2024
  • 2022
  • 2017-2021
  • 131

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $6850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X